CALL FOR ABSTRACTS

Details on the general theme of the congress:

1 - Clinical cases

The communications will highlight the speakers’ conceptions on the homeopathic progress, through their various strategies and the achieved healing levels, (follow-up of the cases and the strategy evolution).

 

How to achieve this – more or less complete - healing and how to appreciate the quality of these healings?

This is the fundamental question that every homeopath has to ask himself.

It also is a question raised by the congress’ theme.

For indeed, logically, a good healing confirms a good strategy. But is it that simple?

From which moment in time did this improvement or healing become apparent?

Which aspects of the person have been modified?

 

The readers will have to give a short comment in order to evaluate the value of the work: they will have to specify the strategy defined by the author of the abstract, once the healing level is achieved.

Which aspect of ‘homeopathy on the move’ has been highlighted?

An evaluation form will have to be completed. This evaluation will be the basis for the selection procedure.

 

-Healing levels

What is a homeopathic healing?

The answer to this question is not straightforward.

This is in fact the challenge of the congress.  It is not enough to say: the patient is feeling better, he has no fever, no eczema anymore or he doesn’t cough anymore, he is healed. 

The question is: what do we want to heal in this patient?

Evidently,  it is the pathology for which he consults a doctor, but is it only that?

Each abstract has to be evaluated in relation to the healing level:

-Level 4: Simillimum: transformation of the patient, physically, mentally, spiritually;

-Level 3: Simile: disappearance of the disease with lasting quality of life;

-Level 2: disappearance or removal of the symptoms;

-Level 1: no healing or palliative care.

 

2 - The provings

Assessment criteria for the abstracts on provings submitted for the LMHI congress in 2014

We can consider a number of categories of abstracts in this context:

(The criteria are listed from most to least important)

 

-Provings of new remedies

1.Respect of the recommendation guidelines of the ECH/LMHI

Be sure that the following information is in the presented text:

- Concerning the studied substance

1.Presentation as complete as possible, name, origin, characteristics and even toxicity

2.The different dilutions used

3.Use or not of ‘blancs’ (placebos, inert pills).

4.Respect for the ethical standards  (informed consent, respected inclusion criteria, clearly defined protocol)

5.Pharmacy or laboratory having prepared the dilutions.

6.Accessibility of the remedy for subsequent prescriptions.

. Concerning the research team

Precise identification (name, address, contact details)

. Concerning the experimenters

Their number, ages and gender.

. Concerning the used methodology

Its precise description.

. Concerning any possible “adverse” events

Their precise description.

 

2. Confirmation of the pathogenetic hypothesis by one or more healed clinical cases.

These will be judged by the established criteria for the presentation of the healed clinical cases.  (See above)

 

- Provings of already known remedies

- Specify, enrich or simply confirm the MM already know of the remedy

- Cross-check the results with those of previous pathogenic studies of the same remedies.

- Respect the ECH/LMHI guidelines

- Clinical confirmation

 

-Theorization on the methodology of provings

1.On the importance of  (non)presence of the placebo presence (first choice as a result of the current collective reflection on this subject)

2.On the importance of double-blind

3.On the importance of the cohort size.

4.Reflections on the methods of listing the pathogenic symptoms.

 

-Historical survey of the practice of provings

To be judged case by case, if this occurs, according to the references of the presentation and the author.

 

3.The clinical studies

Level I: Positive verification of the placebo from several controlled clinical studies.

Level II: Several concordant clinical studies controlled by placebo

Level IIb: A clinical study controlled by placebo

Level IIIa: Several concordant clinical studies of cohorts of patients, statistically comparable.

Level IIIb: A clinical study with a cohort of patients.

Level IV: A clinical case or an expert’s opinion.

 

4.Communications on the homeopathic history and philosophy

Authors have complete freedom.

 

Bibliography

Pay particular attention to the bibliography. Do not list more than 20 references, in order to avoid oversized and redundant bibliographies.